Cryptococcal infection of the central nervous system.
The pathogenesis, clinical signs and symptoms, laboratory manifestations, and laboratory diagnosis of cryptococcal infection of the central nervous system are reviewed, as well as the interaction between the organism and the immune system of the host. In addition, based on our own experience and that of others, the therapy and prognosis of cryptococcal meningitis are discussed.
D000666:Amphotericin B / Q000627:therapeutic use; D002493:Central Nervous System Diseases / Q000134:cerebrospinal fluid / Q000175:diagnosis* / Q000188:drug therapy / Q000503:physiopathology; D003453:Cryptococcosis / Q000134:cerebrospinal fluid / Q000175:diagnosis* / Q000188:drug therapy / Q000503:physiopathology; D005437:Flucytosine / Q000627:therapeutic use; D006801:Humans; D008581:Meningitis / Q000175:diagnosis* / Q000188:drug therapy; D011379:Prognosis
D000666:Amphotericin B; D005437:Flucytosine